MMP9 and diffuse large B-cell lymphoma: In this study, we aim to assess the expression of CD4 and CD8 as T cell markers and macrophage markers (CD68 for M1, MMP9 for M2) in cases of DLBCL and correlate the expression to other clinicopathologic features and clinical outcomes.